DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Receives $35.22 Average Target Price from Analysts

Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAYGet Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the eleven ratings firms that are currently covering the company, MarketBeat Ratings reports. Four investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. The average 1 year price objective among analysts that have covered the stock in the last year is $34.44.

Several brokerages have recently weighed in on XRAY. StockNews.com lowered shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a report on Friday, May 3rd. Piper Sandler reiterated a “neutral” rating and set a $32.00 price objective (down previously from $35.00) on shares of DENTSPLY SIRONA in a report on Friday, May 3rd. Evercore ISI dropped their price objective on shares of DENTSPLY SIRONA from $35.00 to $28.00 and set an “outperform” rating on the stock in a report on Tuesday. Robert W. Baird lowered their target price on shares of DENTSPLY SIRONA from $35.00 to $33.00 and set a “neutral” rating on the stock in a report on Friday, May 3rd. Finally, The Goldman Sachs Group lowered their target price on shares of DENTSPLY SIRONA from $34.00 to $30.00 and set a “neutral” rating on the stock in a report on Monday, May 6th.

View Our Latest Stock Report on DENTSPLY SIRONA

Insiders Place Their Bets

In other news, Director Gregory T. Lucier acquired 3,577 shares of DENTSPLY SIRONA stock in a transaction on Friday, May 31st. The stock was acquired at an average cost of $27.95 per share, with a total value of $99,977.15. Following the transaction, the director now owns 58,374 shares of the company’s stock, valued at approximately $1,631,553.30. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. 0.52% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of XRAY. Bar Harbor Wealth Management purchased a new stake in shares of DENTSPLY SIRONA during the 4th quarter valued at approximately $4,931,000. DAVENPORT & Co LLC purchased a new stake in shares of DENTSPLY SIRONA during the 4th quarter valued at approximately $1,220,000. Dimensional Fund Advisors LP lifted its stake in DENTSPLY SIRONA by 10.3% in the 4th quarter. Dimensional Fund Advisors LP now owns 2,122,355 shares of the medical instruments supplier’s stock worth $75,535,000 after purchasing an additional 197,431 shares in the last quarter. Power Corp of Canada purchased a new stake in DENTSPLY SIRONA in the 4th quarter worth approximately $4,380,000. Finally, Generation Investment Management LLP lifted its stake in DENTSPLY SIRONA by 43.4% in the 4th quarter. Generation Investment Management LLP now owns 6,598,211 shares of the medical instruments supplier’s stock worth $234,830,000 after purchasing an additional 1,998,012 shares in the last quarter. 95.70% of the stock is owned by institutional investors.

DENTSPLY SIRONA Price Performance

XRAY stock opened at $25.16 on Monday. The firm has a market cap of $5.22 billion, a price-to-earnings ratio of -57.18, a PEG ratio of 1.12 and a beta of 1.04. The company has a quick ratio of 0.97, a current ratio of 1.43 and a debt-to-equity ratio of 0.54. DENTSPLY SIRONA has a 12-month low of $24.82 and a 12-month high of $41.65. The company’s fifty day simple moving average is $27.94 and its 200 day simple moving average is $31.81.

DENTSPLY SIRONA (NASDAQ:XRAYGet Free Report) last released its earnings results on Thursday, May 2nd. The medical instruments supplier reported $0.42 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.42. DENTSPLY SIRONA had a negative net margin of 2.41% and a positive return on equity of 11.54%. The business had revenue of $953.00 million for the quarter, compared to analyst estimates of $969.45 million. During the same quarter in the previous year, the business earned $0.39 earnings per share. DENTSPLY SIRONA’s revenue for the quarter was down 2.6% on a year-over-year basis. On average, analysts expect that DENTSPLY SIRONA will post 2.02 earnings per share for the current year.

DENTSPLY SIRONA Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 12th. Shareholders of record on Friday, June 28th will be given a $0.16 dividend. This represents a $0.64 dividend on an annualized basis and a yield of 2.54%. The ex-dividend date is Friday, June 28th. DENTSPLY SIRONA’s payout ratio is -145.45%.

About DENTSPLY SIRONA

(Get Free Report

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.

Read More

Analyst Recommendations for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.